Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02614456
Title Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

Advanced Solid Tumor

Therapies

Nivolumab

Interferon gamma

Age Groups: adult
Covered Countries USA


No variant requirements are available.